The effect of prophylactic carvedilol on subclinical left ventricular dysfunction after 1 cycle FAC chemotherapy in breast cancer patients

BACKGROUND: Despite its efficacy, FAC regimen may cause fatal cardiotoxicity. Carvedilol may also exert additional antioxidant effects. This study aimed to assess the effect of carvedilol in preventing decline of left ventricular function in breast cancer patients receiving FAC regimen chemotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Wibawa Martha, Januar, Soedarsono, Dery A., Iqbal, Mohammad, Astuti, Astri, Martanto, Erwan, Rizki Akbar, Mohammad, Sumantra, I. Gede
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339049/
https://www.ncbi.nlm.nih.gov/pubmed/32671185
http://dx.doi.org/10.1016/j.ijcha.2020.100575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339049/
https://www.ncbi.nlm.nih.gov/pubmed/32671185
http://dx.doi.org/10.1016/j.ijcha.2020.100575

Ejemplares similares